Literature DB >> 7473788

Gene expression in a swine model of right ventricular hypertrophy: intercellular adhesion molecule, vascular endothelial growth factor and plasminogen activators are upregulated during pressure overload.

S M Carroll1, L E Nimmo, P S Knoepfler, F C White, C M Bloor.   

Abstract

We have investigated the molecular changes which occur during pressure overload hypertrophy of the RV in swine. Animals were banded on the pulmonary artery so that right ventricular pressure was increased two-fold. The heart was harvested at 3, 7, 24 and 72 h after surgery. Between 7 and 72 h there was evidence of muscle damage and inflammation. Northern blot experiments showed that pressure overload induced a transient increase in the expression of the immediate early genes and in the developmentally regulated atrial natriuretic factor and skeletal muscle alpha actin genes. Consistent with the histological observations of inflammation, increases in the expression of the gene for intercellular adhesion molecule, which encodes a protein involved in the binding of leukocytes by endothelial cells and myocytes, was observed between 3 and 24 h. In addition, the expression of vascular endothelial growth factor, a growth and permeability factor specific for endothelial cells was increased at 3 and 7 h of pressure overload. An increase in the expression of urokinase plasminogen activator and its inhibitors, plasminogen activator inhibitors I and II, was also observed between 3 and 24 h. This was associated with an increase in urokinase activity in the myocardial tissue. These results indicate that hypertrophy in a large mammal such as swine induces a program of gene expression similar to that previously described in rodents and suggests that up-regulation of a variety of other genes is an early response to pressure overload.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7473788     DOI: 10.1006/jmcc.1995.0135

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  7 in total

Review 1.  Role of vascular permeability factor/vascular endothelial growth factor in eye disease.

Authors:  R O Schlingemann; V W van Hinsbergh
Journal:  Br J Ophthalmol       Date:  1997-06       Impact factor: 4.638

2.  Effects of gradual coronary artery occlusion and exercise training on gene expression in swine heart.

Authors:  Marvin O Boluyt; Georgina M Cirrincione; Amy M Loyd; Donna H Korzick; Janet L Parker; M Harold Laughlin
Journal:  Mol Cell Biochem       Date:  2006-08-26       Impact factor: 3.396

3.  Increased gene expression of plasminogen activators and inhibitors in left ventricular hypertrophy.

Authors:  C M Bloor; L Nimmo; M D McKirnan; Y Zhang; F C White
Journal:  Mol Cell Biochem       Date:  1997-11       Impact factor: 3.396

4.  Loss or inhibition of uPA or MMP-9 attenuates LV remodeling and dysfunction after acute pressure overload in mice.

Authors:  Stephane Heymans; Florea Lupu; Sven Terclavers; Bjorn Vanwetswinkel; Jean-Marc Herbert; Andrew Baker; Desire Collen; Peter Carmeliet; Lieve Moons
Journal:  Am J Pathol       Date:  2005-01       Impact factor: 4.307

5.  Increased expression of plasminogen activator inhibitor-1 in cardiomyocytes contributes to cardiac fibrosis after myocardial infarction.

Authors:  Kyosuke Takeshita; Mutsuharu Hayashi; Shigeo Iino; Takahisa Kondo; Yasuya Inden; Mitsunori Iwase; Tetsuhito Kojima; Makoto Hirai; Masafumi Ito; David J Loskutoff; Hidehiko Saito; Toyoaki Murohara; Koji Yamamoto
Journal:  Am J Pathol       Date:  2004-02       Impact factor: 4.307

6.  Maternal nutrient restriction and the fetal left ventricle: decreased angiotensin receptor expression.

Authors:  Jeffrey S Gilbert; Alvin L Lang; Mark J Nijland
Journal:  Reprod Biol Endocrinol       Date:  2005-07-14       Impact factor: 5.211

Review 7.  α-Enolase, a multifunctional protein: its role on pathophysiological situations.

Authors:  Angels Díaz-Ramos; Anna Roig-Borrellas; Ana García-Melero; Roser López-Alemany
Journal:  J Biomed Biotechnol       Date:  2012-10-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.